European Ocean Biodiversity Information System
[ report an error in this record ]basket (1): add | show Print this page
one publication added to basket [252680]
The marine biodiscovery pipeline and ocean medicines of tomorrow
Jaspars, M.; De Pascale, D.; Andersen, J.H.; Reyes, F.; Crawford, A.D.; Ianora, A. (2016). The marine biodiscovery pipeline and ocean medicines of tomorrow. J. Mar. Biol. Ass. U.K. 96(1): 151-158. https://hdl.handle.net/10.1017/s0025315415002106
In: Journal of the Marine Biological Association of the United Kingdom. Cambridge University Press/Marine Biological Association of the United Kingdom: Cambridge. ISSN 0025-3154; e-ISSN 1469-7769
Related to:
Thorndyke, M.; McGowan, F.; Fleming, L.; Solo-Gabriele, H. (Ed.) (2016). Oceans and Human Health. Journal of the Marine Biological Association of the United Kingdom, 96(1). Cambridge University Press: Cambridge. 216 pp., more
Peer reviewed article  
Available in  Authors 
    Vlaams Instituut voor de Zee: Open access 283842 [ download pdf ]
Keyword
    Marine/Coastal
Author keywords
    drug discovery, ocean medicines, PharmaSea project
Authors  Top 
  • Jaspars, M.
  • De Pascale, D.
  • Andersen, J.H.
  • Reyes, F.
  • Crawford, A.D.
  • Ianora, A.
Abstract
    Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.
All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors